Ann MacDougall

Track

Insider profile

Currently holds a position at Opiant Pharmaceuticals Inc

Performance

Overall performance
2.1
Performance over holding periods
2.1
30 days 90 days 120 days
Average return 4% 8.2% 15.1%
Success rate 83% 68% 82%
Transactions
4 25% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Director Opiant Pharmaceuticals Inc May 5, 2016 -
Ann MacDougall's trades of Opiant Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
336.70
Quantity 4,452 -8.4%
Value US$4,182,211
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-05-16 2022-05-13
B Purchase
4,452 -8.4%
336.70
US$4,182,211 		4,452 -8.4% 336.70 US$4,182,211
2021-03-17 2021-03-17
S Sale
93,215 -26.9%
457.84
US$3,976,636 		93,215 -26.9% 457.84 US$3,976,636
2021-03-17 2021-03-16
S Sale
62,817 +47.0%
53.08
US$2,884,515 		62,817 +47.0% 53.08 US$2,884,515
2021-03-17 2021-03-15
S Sale
5,600 -22.0%
11.63
US$65,128 		5,600 -22.0% 11.63 US$65,128